NMR based blood tests can detect and differentiate cancer even when a patient is asymptomatic, opening up possibilities of annual checks
![](https://justcarehealth.com/wp-content/uploads/2022/12/image-61-1024x576.png)
For a mixed group of patients referred from primary care with nonspecific signs and symptoms, NMR-based metabolomics can assist their diagnosis. It may differentiate those with malignancies and those with and without metastatic disease. Respectively, the maximum sensitivity and specificity were 94% and 82%. We could also identify patients with metastatic disease in the cohort of patients with cancer with sensitivity and specificity of 94% and 88%, respectively.